廣東粵運交通(03399.HK)斥1.74億人幣潮州粵運及珠海拱運股權
廣東粵運交通(03399.HK)公布,斥1.04億元人民幣購潮州粵運股權,及7,160.74萬元人民幣購珠海拱運股權分別訂立轉讓協議。
潮州粵運及珠海拱運主要從事道路運輸業務,與集團為出行服務一體化平台的戰略發展規劃一致。收購上述資產可幫助集團進一步明確界定其戰略定位、強化其出行服務業務及發展集團各業務板塊間的協同效應。
公司主席禤宗民指,正在積極推進其A股上市工作,上市審核對上市公司同業競爭的問題有嚴格要求,而潮州粵運及珠海拱運目前從事業務與集團存在同類業務。通過本次收購,更增強了集團的獨立性,使集團更好的符合中國證券監督管理委員會的上市審核要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.